BioGaia has today extended its global contract with Nestle Nutrition by signing an agreement with the company’s UK infant nutrition business for the exclusive rights to sell BioGaia’s ProTectis Baby Drops in the United Kingdom and Ireland.
The launch is planned to take place in the beginning of 2015.
Nestle Nutrition U.K. will market both BioGaia ProTectis Baby Drops, which is BioGaia's biggest product, and BioGaia ProTectis Baby Drops with vitamin D. Both products contain BioGaia's patented and well-documented probiotic strain Lactobacillus reuteri Protectis. Today the drops are sold in 60 countries worldwide.
“I am delighted that we after many years of preparations have been able to conclude a contract for this large market. We have established an important key opinion leader network in the U.K. and the drops are already sold in a few hospital pharmacies. Considering Nestle Nutrition’s presence in the market and our preparatory work I am convinced that sales will expand quickly”, says Peter Rothschild, President, BioGaia.